These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25725107)

  • 1. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages.
    Shimizu K; Nakajima A; Sudo K; Liu Y; Mizoroki A; Ikarashi T; Horai R; Kakuta S; Watanabe T; Iwakura Y
    J Immunol; 2015 Apr; 194(7):3156-68. PubMed ID: 25725107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions.
    Pou J; Martínez-González J; Rebollo A; Rodríguez C; Rodríguez-Calvo R; Martín-Fuentes P; Cenarro A; Civeira F; Laguna JC; Alegret M
    Biochim Biophys Acta; 2011 Sep; 1811(9):556-63. PubMed ID: 21683158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses.
    Martin P; Palmer G; Rodriguez E; Seemayer CA; Palomo J; Talabot-Ayer D; Gabay C
    J Immunol; 2017 Apr; 198(7):2916-2926. PubMed ID: 28235865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
    Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
    Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions.
    Martin P; Palmer G; Vigne S; Lamacchia C; Rodriguez E; Talabot-Ayer D; Rose-John S; Chalaris A; Gabay C
    J Leukoc Biol; 2013 Oct; 94(4):791-802. PubMed ID: 23817563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface.
    Uchikawa S; Yoda M; Tohmonda T; Kanaji A; Matsumoto M; Toyama Y; Horiuchi K
    Cytokine; 2015 Feb; 71(2):238-45. PubMed ID: 25461404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12p35 promotes antibody-induced joint inflammation by activating NKT cells and suppressing TGF-beta.
    Park Y; Kim HS; Ahn JY; Yun D; Cho ML; Hong S; Kim HY; Chung DH
    J Immunol; 2010 Aug; 185(3):1476-84. PubMed ID: 20581146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of interleukin-1 receptor type II enhances cell migration through activation of the pre-interleukin 1alpha pathway.
    Chang SY; Su PF; Lee TC
    Cytokine; 2009 Jan; 45(1):32-8. PubMed ID: 19026558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine tumor necrosis factor α-induced adipose-related protein (tumor necrosis factor α-induced protein 9) deficiency leads to arthritis via interleukin-6 overproduction with enhanced NF-κB, STAT-3 signaling, and dysregulated apoptosis of macrophages.
    Inoue A; Matsumoto I; Tanaka Y; Umeda N; Tanaka Y; Mihara M; Takahashi S; Sumida T
    Arthritis Rheum; 2012 Dec; 64(12):3877-85. PubMed ID: 22886597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis.
    Bessis N; Guéry L; Mantovani A; Vecchi A; Sims JE; Fradelizi D; Boissier MC
    Eur J Immunol; 2000 Mar; 30(3):867-75. PubMed ID: 10741403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocytes/macrophages and/or neutrophils are the target of IL-10 in the LPS endotoxemia model.
    Pils MC; Pisano F; Fasnacht N; Heinrich JM; Groebe L; Schippers A; Rozell B; Jack RS; Müller W
    Eur J Immunol; 2010 Feb; 40(2):443-8. PubMed ID: 19941312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin 1 and interleukin 2 in rat and mouse arthritis models.
    Phadke K; Carlson DG; Gitter BD; Butler LD
    J Immunol; 1986 Jun; 136(11):4085-91. PubMed ID: 3486226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
    Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
    Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of IL-1 signaling by the decoy receptor IL-1R2.
    Schlüter T; Schelmbauer C; Karram K; Mufazalov IA
    J Mol Med (Berl); 2018 Oct; 96(10):983-992. PubMed ID: 30109367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.
    Oelmann E; Stein H; Berdel WE; Herbst H
    PLoS One; 2015; 10(9):e0138747. PubMed ID: 26406983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.
    Hartgring SA; Willis CR; Alcorn D; Nelson LJ; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Sep; 62(9):2716-25. PubMed ID: 20499386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.